Human Genome Epidemiology Literature Finder
|
Records 1 - 9 (of 9 Records) |
| Query Trace: Disease and RRM1[original query] |
|---|
| Influence of genetic markers on survival in non-small cell lung cancer. Drugs of today (Barcelona, Spain : 1998) 2003 Oct 39 (10): 775-86. Rosell Rafael, Taron Miquel, Camps Carlos, López-Vivanco Guiller |
| Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine. Lung cancer (Amsterdam, Netherlands) 2011 Feb 71 (2): 191-8. Viñolas N, Provencio M, Reguart N, Cardenal F, Alberola V, Sánchez-Torres J M, Barón F J, Cobo M, Maestu I, Moreno I, Mesía C, Izquierdo A, Felip E, López-Brea M, Márquez A, Sánchez-Ronco M, Tarón M, Santarpia M C, Rosell R, |
| A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research. Investigational new drugs 2012 Jun 30 (3): 1164-74. Oh Do-Youn, Lee Keun Wook, Lee Kyung-Hee, Sohn Chang-Hak, Park Young Suk, Zang Dae Young, Ryoo Hun-Mo, Song Hong-Suk, Kim Jin-Soo, Kang Hye-Jin, Kim Bong-Seog, Bang Yung-J |
| Prediction of a side effect and efficacy of adjuvant chemotherapy with gemcitabine for post operative patient of pancreatic cancer by a genetic polymorphism analysis. Hepato-gastroenterology 0 59 (117): 1609-13. Kasuya Kazuhiko, Tsuchida Akihiko, Nagakawa Yuichi, Suzuki Yoshiaki, Suzuki Minako, Aoki Tatsuya, Abe Yuta, Shimazu Motohide, Itoi Takao, Sofuni Atsus |
| Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer. Cancer prevention research (Philadelphia, Pa.) 2012 Mar 5 (3): 365-73. de Andrade Mariza, Li Yan, Marks Randolph S, Deschamps Claude, Scanlon Paul D, Olswold Curtis L, Jiang Ruoxiang, Swensen Stephen J, Sun Zhifu, Cunningham Julie M, Wampfler Jason A, Limper Andrew H, Midthun David E, Yang Pi |
| Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients. Oncology reports 2013 Nov 30 (5): 2385-98. Mlak Rados?aw, Krawczyk Pawe?, Ramlau Rodryg, Kalinka-Warzocha Ewa, Wasylecka-Morawiec Maja, Wojas-Krawczyk Kamila, Kucharczyk Tomasz, Homa Iwona, Kozio? Piotr, Ciesielka Marzanna, Chudziak Dorota, Milanowski Janu |
| A Survival Association Study of 102 Polymorphisms Previously Associated with Survival Outcomes in Colorectal Cancer. BioMed research international 2015 2015 968743. Savas Sevtap, Xu Jingxiong, Werdyani Salem, Shestopaloff Konstantin, Dicks Elizabeth, Green Jane, Parfrey Patrick, Green Roger, Xu W |
| RRM1, RRM2 and ERCC2 Gene Polymorphisms in Coronary Artery Disease. In vivo (Athens, Greece) 0 30 (5): 611-5. Altinkilic Emre Murat, Isbir Selim, Gormus Uzay, Yilmaz Seda Gulec, Dalan Altay Burak, Duman Selvi, Isbir Turg |
| Investigation of some DNA repair genes association in non small cell lung cancer. Cellular and molecular biology (Noisy-le-Grand, France) 2015 61 (8): 57-62. Coskunpinar E, Yildiz P, Aynaci E, Turna A, Musteri Oltulu Y, Hekimoglu E, Isbir T, Yaylim |
- Page last reviewed:Feb 1, 2024
- Content source:

